BeiGene, Ltd. (6160.HK)

HKD 105.9

(-1.4%)

Revenue Summary of BeiGene, Ltd.

  • BeiGene, Ltd.'s latest annual revenue in 2023 was 2.45 Billion USD , up 73.65% from previous year.
  • BeiGene, Ltd.'s latest quarterly revenue in 2024 Q2 was 929.16 Million USD , up 23.62% from previous quarter.
  • BeiGene, Ltd. reported a annual revenue of 1.41 Billion USD in annual revenue 2022, up 20.37% from previous year.
  • BeiGene, Ltd. reported a annual revenue of 1.17 Billion USD in annual revenue 2021, up 280.83% from previous year.
  • BeiGene, Ltd. reported a quarterly revenue of 751.65 Million USD for 2024 Q1, up 18.48% from previous quarter.
  • BeiGene, Ltd. reported a quarterly revenue of 634.4 Million USD for 2023 Q4, down -18.8% from previous quarter.

Annual Revenue Chart of BeiGene, Ltd. (2023 - 2013)

Historical Annual Revenue of BeiGene, Ltd. (2023 - 2013)

Year Revenue Revenue Growth
2023 2.45 Billion USD 73.65%
2022 1.41 Billion USD 20.37%
2021 1.17 Billion USD 280.83%
2020 308.87 Million USD -27.87%
2019 428.21 Million USD 116.03%
2018 198.22 Million USD -16.85%
2017 238.38 Million USD 22179.16%
2016 1.07 Million USD -87.86%
2015 8.81 Million USD -32.37%
2014 13.03 Million USD 16.93%
2013 11.14 Million USD 0.0%

Peer Revenue Comparison of BeiGene, Ltd.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD -407.26%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 53.806%